February 2026 Dispatch - Engineered Resilience

Highlights this month include: global exposome initiative backed by UNESCO, air pollution-Alzheimer's link in 28M Americans, PFAS+microplastics synergistic toxicity, prenatal PFAS exposure mapped via cord blood, p-tau217 biomarker predicts dementia onset, TSCA rollback threats, and UK PFAS Plan.

Exposures & Mechanisms

[Bench] PFAS and microplastics show synergistic toxicity across human cell lines (Environment International)
University of Birmingham found 59% additive and 41% synergistic interactions between PFAS and microplastics. Combined exposure caused developmental failures, delayed sexual maturity, and stunted growth exceeding effects of either chemical alone.

[Bench] Cord blood reveals newborns exposed to far more PFAS than previously known (MedicalXpress)
Mount Sinai researchers used data science methods to estimate total prenatal PFAS exposure from archived umbilical cord blood. Results showed infants exposed to perfluorinated chemicals, polyfluorinated chemicals, and fluorotelomers before birth.

[Translation] Air pollution directly harms brains—not just via heart disease—in 28M older Americans (ScienceDaily)
Emory study in PLOS Medicine found long-term PM2.5 exposure linked to higher Alzheimer's likelihood. Connection stems from pollution's direct effects on the brain rather than through related conditions like hypertension.

[Bench] Microplastics adsorb onto aged plastics at up to 100% efficiency (ScienceDirect)
Among 18 polymers studied, polyamides exhibit the highest PFAS uptake. Smaller, aged, or biofilm-covered microplastics retain 20-85% more PFAS depending on environmental conditions—amplifying mixture toxicity.

[Bench] Pandemic air quality changes weakened atmosphere's methane cleanup (ScienceDaily)
Methane surged in early 2020s partly because reduced air pollution weakened the atmosphere's natural breakdown process. Wet conditions also boosted emissions from wetlands and rice fields—demonstrating exposure interconnections.

Early Detection & Biomarkers

[Translation] p-tau217 blood test predicts Alzheimer's symptom onset years in advance (ScienceDaily)
Plasma p-tau217 levels now enable estimation of when someone may begin experiencing Alzheimer's symptoms. Published in Nature Medicine as part of the NIH Biomarkers Consortium.

[Translation] Global Exposome Initiative launches with UNESCO backing (ScienceDaily)
Scientists launch ambitious global effort to map the "human exposome"—lifelong environmental and chemical exposures driving most diseases. Powered by AI and advanced data tools across multiple continents.

[Bench] Exposome framework generates ExpTox scores for chemical prioritization (Environment International)
New framework integrates human biomonitoring data, exposome datasets, and toxicity information. Exposure data substantially reshaped which chemicals are prioritized for safety evaluation.

[Translation] Buck Institute creates molecular maps of aging joints (Buck Institute)
Spatial mass spectrometry reveals pre-symptomatic aging signatures in knee joints, enabling earlier intervention for osteoarthritis before irreversible damage.

AI & Biotech Platforms

[Bench] PDGrapher predicts therapeutic perturbations 25x faster (Nature Biomedical Engineering)
Causally inspired neural network solves the inverse problem: predicting which genetic targets shift gene expression from diseased to normal states. Trains 25x faster than existing methods.

[Translation] ARPA-H PROSPR program funds $144M in healthspan trials (UConn Today)
$22M contract supports clinical trial testing whether HIV drug reduces DNA-triggered inflammation in 200 adults aged 60-65. Part of broader $144M PROSPR initiative treating aging as tractable.

[Bench] Allen Brain Cell Atlas releases Early-Winter 2026 data (Allen Institute)
New consensus taxonomy plus 5.4M human basal ganglia cells and 4.5M macaque cells. Aging mouse transcriptomic data enables cross-species exposure-response comparisons.

Chemical Policy & Accountability

[Policy] TSCA rollback draft threatens chemical safety protections (Toxic-Free Future)
Senate draft legislation would dismantle core protections of the Toxic Substances Control Act. Hearing scheduled for March 4, 2026.

[Policy] UK releases PFAS Plan with three-pillar regulatory framework (BCLP Law)
UK government commits to monitoring 2,400 freshwater samples annually and deploying PFAS mapping tool by end of 2026. Framework focuses on understanding, intervention, and protection.

[Policy] Executive order designates glyphosate critical to national security (EWG)
Defense Production Act invoked to guarantee glyphosate-based herbicide supply despite neurodegeneration concerns.

[Policy] New York introduces paraquat ban legislation (EWG)
Legislation targets one of the most toxic herbicides in the U.S. following Parkinson's disease evidence via alpha-synuclein aggregation.

[Policy] California bill mandates heavy metal testing in protein powders (EWG)
Proposed legislation addresses consumer safety gap in dietary supplements.

Defense & Active Clearance

[Defense] Cholestyramine PFAS clearance trials expand (C&EN)
Three recent studies probe cholestyramine-PFAS link. One patient saw two fluorinated chemicals become nearly undetectable after 8 months of treatment.

[Defense] Oregon wood preserver documented for 30+ chemical spill incidents (KPTV)
Oregon DEQ documented repeated pentachlorophenol spills at Stella-Jones facility. Site designated as federal Superfund location.

[Bench] Silent Spring: 90%+ of hair extensions contain toxic chemicals (Silent Spring Institute)
Products contain toxic organotins, flame retardants, phthalates linked to cancer and hormone disruption.

[Bench] Understudied PFAS precursors dominate household dust (Silent Spring Institute)
Rochester pilot study reveals regulatory focus may miss dominant PFAS exposure pathway—precursors rather than legacy compounds.

Summary: 20 articles | Bench: 9 | Translation: 5 | Policy: 5 | Defense: 4

The Engineered Resilience Dispatch has been curated for you using carefully managed scripts with a human-in-the-loop. If we've missed a point or if you have recommendations of topics/groups to follow, we'd love to hear it. Contact Us